Skip to main content

Post-IPO Secondary Biotechnology Companies

Explore 7 biotechnology startups that raised post-ipo secondary funding. Access verified founder contact information and fundraising data.

Total Companies
7
Total Funding
$1.3B
Avg Funding
$186.7M
Cities
6

Export 7 Post-IPO Secondary Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Warsaw, Poland
$12.6M
raised

Molecure is an innovative biopharmaceutical company that specializes in discovery, development, and commercialization of novel therapeutics.

Jul 2023
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

Chellaston, United Kingdom
$3.6M
raised

Thalia Therapeutics is a drug reformulation company.

Jun 2026
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

New York, United States
$6.8M
raised

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.

May 2026
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

Broadview Heights, United States
$486.0M
raised

Sotera Health is an integrated global health solutions provider.

May 2026
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$50.0M
raised

Werewolf Therapeutics operates as an oncology biotherapeutics company.

May 2022
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 7 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$500.0M
raised

Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.

Nov 2025
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

Plymouth Meeting, United States
$248.0M
raised

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Oct 2024
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

Ready to Connect with Post-IPO Secondary Biotechnology Startups?

Get verified founder emails, funding details, and company data for 7 post-ipo secondary biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked